Establishing a clinical trial center in a Traditional Medicine Hospital: a strategic framework for standardizing operations and ensuring good clinical practice compliance

Authors

  • Quoc Huy Nguyen Author
  • Manh Cuong Le Author
  • Thuy Phuong Pham Author
  • Nguyễn Văn Khiêm Vietnam University of Traditional Medicine Author

Keywords:

Clinical trials, Good Clinical Practice, Traditional medicine, Quality management, Herbal medicine

Abstract

Establishing a clinical trial center within a traditional medicine hospital is an increasingly important requirement for transitioning from fragmented research activities to a structured, well-governed clinical research system that complies with Good Clinical Practice (GCP). This review analyzes the core components required to standardize a clinical trial center, including governance, human resources, infrastructure, standardized procedures, participant safety, investigational product management, data integrity, quality management, and regulatory compliance. The analysis is informed by major international guidance and relevant literature, including ICH E6(R3), the 2024 Declaration of Helsinki, CIOMS/WHO guidance, and the WHO Traditional Medicine Strategy. A clinical trial center should not be defined primarily by its physical size or equipment, but by an integrated system of governance, standardized processes, clearly assigned responsibilities, and quality control. Standard Operating Procedures (SOPs) constitute a key operational instrument within the quality assurance system. For herbal medicines and traditional medicines, specific challenges, including batch-to-batch variability in active constituents, the feasibility of placebo development, herb–drug interactions, and pharmacovigilance require careful assessment and should be incorporated into both trial design and the operational framework of the clinical trial center from the outset. This article proposes a roadmap for establishing clinical trial centers in traditional medicine hospitals, with an emphasis on developing an integrated clinical research system, implementing GCP-compliant standards, and creating a foundation for participation in multicenter studies and integration into national and international clinical research networks.

References

1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Harmonised Guideline: Guideline for Good Clinical Practice E6(R3). Final version. Adopted 6 January 2025.

2. World Health Organization. Global Traditional Medicine Strategy 2025–2034. Geneva: WHO; 2025.

3. World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human participants. JAMA. 2025;333(1):71-74. DOI: 10.1001/jama.2024.21972

4.Merson L, Witt K, Hussaini A, et al. Infrastructure, capabilities, and capacities required for clinical trials design and delivery: a rapid scoping review of recommendations and regulations. Wellcome Open Res. 2024;9:729. DOI: 10.12688/wellcomeopenres.23135.2

5. Franzen SR, Chandler C, Lang T. Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature. BMJ Open. 2017;7(1). DOI: 10.1136/bmjopen-2016-012332

6. World Health Organization. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Geneva: WHO; 2000. WHO/EDM/TRM/2000.1.

7. Parveen A, Parveen B, Parveen R, Ahmad S. Challenges and guidelines for clinical trial of herbal drugs. J Pharm Bioallied Sci. 2015;7(4):329-333. DOI: 10.4103/0975-7406.168035

8. Hu Y, Wang Z, Ni K, Yang J. Challenges in traditional Chinese medicine clinical trials: how to balance personalized treatment and standardized research? Ther Clin Risk Manag. 2025;21:1085-1094. DOI: 10.2147/TCRM.S523279

9. Choudhury A, Singh PA, Bajwa N, Dash S, Bisht P. Pharmacovigilance of herbal medicines: concerns and future prospects. J Ethnopharmacol. 2023;309:116383. DOI: 10.1016/j.jep.2023.116383

10. Sehgal S, Pua EC, Rojevsky S, et al. A maturity model for Clinical Trials Management Ecosystem. J Clin Transl Sci. 2025;9(1). DOI: 10.1017/cts.2024.1168

11. Bell LA, Gurnett R, Goss CE, et al. Capacity building at an Australian regional clinical trials unit: determinants of growth and correlation with a capability framework. BMC Med Res Methodol. 2026;26:170. DOI: 10.1186/s12874-026-02902-4

12. Quốc hội nước Cộng hòa xã hội chủ nghĩa Việt Nam. Luật Dược số 105/2016/QH13 ngày 06/4/2016, được sửa đổi, bổ sung bởi Luật số 28/2018/QH14 và Luật số 44/2024/QH15 ngày 21/11/2024 (hiệu lực thi hành từ 01/7/2025).

13. Bộ Y tế. Thông tư số 50/2025/TT-BYT ngày 31/12/2025 quy định về thử thuốc trên lâm sàng.

14. Nair SC, AlGhafli S, AlJaberi A. Developing a clinical trial governance framework for pharmaceutical industry-funded clinical trials. Account Res. 2018 ;25(7-8):373-386. DOI: 10.1080/08989621.2018.1527222

15. Sellers JW, Mihaescu CM, Ayalew K, et al. Descriptive analysis of Good Clinical Practice inspection findings from U.S. Food and Drug Administration and European Medicines Agency. Ther Innov Regul Sci. 2022;56(5):753-764. DOI: 10.1007/s43441-022-00417-w

16. Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO). International Ethical Guidelines for Health-related Research Involving Humans. Geneva: CIOMS; 2016. DOI: 10.56759/rgxl7405

17. Bộ Y tế. Thông tư số 43/2024/TT-BYT ngày 12/12/2024 quy định việc thành lập, tổ chức và hoạt động của Hội đồng đạo đức trong nghiên cứu y sinh học.

18. Mandava A, Pace C, Campbell B, Emanuel E, Grady C. The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries. J Med Ethics. 2012;38(6):356-365. DOI: 10.1136/medethics-2011-100178

19. European Medicines Agency. Guideline on Computerised Systems and Electronic Data in Clinical Trials. Amsterdam: EMA; 2023.

20. Florez M, Dirks A, Sullivan L, Young S, Getz K. Adoption maturity model for risk-based quality management (RBQM) in clinical trials. Ther Innov Regul Sci. 2025;59(3):549-557. DOI: 10.1007/s43441-025-00746-6

21. Dirks A, Florez M, Torche F, Young S, Slizgi B, Getz K. Comprehensive assessment of risk-based quality management adoption in clinical trials. Ther Innov Regul Sci. 2024;58(3):520-527. DOI: 10.1007/s43441-024-00618-5

22. Barnes B, Stansbury N, Brown D, et al. Risk-based monitoring in clinical trials: past, present, and future. Ther Innov Regul Sci. 2021;55(4):899-906. DOI: 10.1007/s43441-021-00295-8

23. DuBois JM, Mozersky JT, Antes AL, Baldwin K, Jenkerson M. Assessing clinical research coordinator knowledge of good clinical practice: an evaluation of the state of the art and a test validation study. J Clin Transl Sci. 2020;4(2):141-145. DOI: 10.1017/cts.2019.440

24. Calvin-Naylor NA, Jones CT, Wartak MM, et al. Education and training of clinical and translational study investigators and research coordinators: a competency-based approach. J Clin Transl Sci. 2017;1(1):16-25. DOI: 10.1017/cts.2016.2

25.Liang N, Zhang Y, Zhang X, et al. International Traditional Medicine Clinical Trial Registry: a meaningful initiative and its future development. J Evid Based Med. 2024;17(3):486-489. DOI: 10.1111/jebm.12651

Publication Date

01-12-2026

How to Cite

Establishing a clinical trial center in a Traditional Medicine Hospital: a strategic framework for standardizing operations and ensuring good clinical practice compliance. (2026). DA NANG JOURNAL OF MEDICINE AND PHARMACY, 2(4), 9-21. https://tapchi.ydn.edu.vn/index.php/yduoc/article/view/132

Similar Articles

1-10 of 81

You may also start an advanced similarity search for this article.